Obsessional states.
D000367:Age Factors; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001007:Anxiety / Q000150:complications; D001521:Behavior Therapy; D003193:Compulsive Personality Disorder / Q000150:complications / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery / Q000628:therapy; D011379:Prognosis; D011612:Psychosurgery; D011613:Psychotherapy
D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors